Uday B. Kompella Ph.D.
Net Worth

Last updated:

What is Uday B. Kompella Ph.D. net worth?

The estimated net worth of Dr. Uday B. Kompella Ph.D. is at least $8,468,159 as of 2 Nov 2021. He owns shares worth $154,447 as insider, has earned $8,134,632 from insider trading and has received compensation worth at least $179,080 in Ocugen, Inc..

What is the salary of Uday B. Kompella Ph.D.?

Dr. Uday B. Kompella Ph.D. salary is $44,770 per year as Co-founder & Independent Director in Ocugen, Inc..

How old is Uday B. Kompella Ph.D.?

Dr. Uday B. Kompella Ph.D. is 58 years old, born in 1967.

What stocks does Uday B. Kompella Ph.D. currently own?

As insider, Dr. Uday B. Kompella Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Ocugen, Inc. (OCGN) Co-founder & Independent Director 154,416 $1 $154,447

What does Ocugen, Inc. do?

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

OCGN logo
OCGN
Ocugen, Inc.
$1

Uday B. Kompella Ph.D. insider trading

Ocugen, Inc.

Dr. Uday B. Kompella Ph.D. has made 14 insider trades in 2021, according to the Form 4 filled with the SEC. Most recently he sold 25,000 units of OCGN stock worth $400,250 on 2 Nov 2021.

The largest trade he's ever made was exercising 350,000 units of OCGN stock on 26 Apr 2021. As of 2 Nov 2021 he still owns at least 154,416 units of OCGN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 25,000 $16.01 $400,250
Sale
Common Stock 25,000 $14.05 $351,250
Sale
Common Stock 25,000 $12.05 $301,250
Sale
Common Stock 46,371 $9.08 $421,049
Sale
Common Stock 1,898 $9.01 $17,101
Sale
Common Stock 1,731 $9.02 $15,614
Sale
Common Stock 200,000 $8.41 $1,682,000
Sale
Common Stock 10,000 $1.83 $18,300
Option
Common Stock 10,000 $1.83 $18,300
Option
Option (right to buy) 10,000 $1.83 $18,300
Option
Option (right to buy) 10,000 $1.83 $18,300
Option
Common Stock 10,000 $1.83 $18,300
Sale
Common Stock 10,000 $1.83 $18,300
Option
Option (right to buy) 7,191 $1.88 $13,519
Option
Common Stock 7,191 $1.88 $13,519
Sale
Common Stock 7,191 $1.88 $13,519
Sale
Common Stock 50,000 $16.02 $801,000
Sale
Common Stock 50,000 N/A N/A
Sale
Common Stock 20,000 N/A N/A
Option
Common Stock 20,000 N/A N/A
Option
Option (right to buy) 20,000 N/A N/A
Sale
Common Stock 350,000 $11.7 $4,095,000

Ocugen key executives

Ocugen, Inc. executives and other stock owners filed with the SEC:

  • Dr. Shankar Musunuri M.B.A., MBA, Ph.D. (61) Co-Founder, Chairman & Chief Executive Officer
  • Dr. Uday B. Kompella Ph.D. (58) Co-founder & Independent Director
  • Mr. Sanjay S. Subramanian M.B.A. (49) Chief Accounting Officer, Chief Financial Officer, Treasurer, Head of Corporation Devel. & Corporation Sec.